Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 18, 2022American Journal of HematologyOpen Access

Venetoclax combined with FLAG‐IDA induction and consolidation in newly diagnosed acute myeloid leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

CDCourtney D. DiNardoThe University of Texas MD Anderson Cancer CenterCLCurtis A. LachowiezOregon Health & Science UniversityKTKoichi TakahashiKurume University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

DiNardo et al. (2022) studied this question.

synapsesocial.com/papers/6a17592fa0e670aec86e8985https://doi.org/10.1002/ajh.26601
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML2020 · 687 citations
  2. 2Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia2020 · 2,949 citations
  3. 3Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia2021 · 83 citations
  4. 4Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia1994 · 1,441 citations
  5. 5Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel2016 · 5,999 citations